Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-18T10:40:14.883Z Has data issue: false hasContentIssue false
  • English
  • Français

Results for audiology and distortion product and transient evoked otoacoustic emissions in patients with systemic lupus erythematosus

Published online by Cambridge University Press:  26 October 2009

H Karabulut ,
M Dagli ,
A Ates  and
Y Karaaslan
H Karabulut
Affiliation:
Otolaryngology Department, Ankara Keciören Research and Training Hospital, Turkey
M Dagli*
Affiliation:
Department of Otolaryngology, Ankara Numune Research and Training Hospital, Turkey
A Ates
Affiliation:
Department of Rheumatology, Ankara Numune Research and Training Hospital, Turkey
Y Karaaslan
Affiliation:
Department of Rheumatology, Ankara Numune Research and Training Hospital, Turkey
*
Address for correspondence: Dr Muharrem Dagli, Cemal Gursel Caddesi no 48/1, Cebeci 06600, Ankara, Turkey. Fax: 903124358832 E-mail: mdagli@hotmail.com
Get access Rights & Permissions [Opens in a new window]

Abstract

The aim of the current study was to investigate hearing loss and cochlear function in patients with systemic lupus erythematosus, using audiology, distortion product otoacoustic emissions and transient evoked otoacoustic emissions.

Study design:

Prospective, case–control study.

Methods:

The study included 26 randomised patients with systemic lupus erythematosus (52 ears) and 30 healthy control subjects (60 ears). Pure tone audiometry was performed at 250 and 500 Hz and at 1, 2, 4, 6, 8, 10, 12, 14 and 16 kHz. Distortion product otoacoustic emissions and transient evoked otoacoustic emissions were measured using Biologic System equipment with Scout Acoustic Emissions System software.

Results:

The distortion product otoacoustic emission signal responses were significantly different only at 750 Hz, while the distortion product otoacoustic emission signal–noise ratios were significantly different at 750 Hz and 6 kHz (p < 0.05), comparing patients and controls. The transient evoked otoacoustic emission signal–noise ratios were significantly different at 2 and 3 kHz, comparing patients and controls (p < 0.05). The transient evoked otoacoustic emission total signal–noise ratios were significantly different, comparing patients and controls (p < 0.05). In addition, the pure tone audiometry thresholds were significantly different at 250 and 500 Hz and at 1, 2, 10 and 12 kHz, comparing patients and controls (p < 0.05).

Conclusion:

Our findings do not completely agree with those of previous temporal bone histopathological studies. However, our results do support a general picture of low frequency hearing loss in systemic lupus erythematosus patients. We consider these results to be related to endolymphatic and cochlear hydrops, and we suggest that electrocochleography could be performed in further studies for clarification of this subject.

Keywords

Systemic Lupus ErythematosusHearing LossInner EarOtoacoustic Emissions
Type
Main Articles
Information
The Journal of Laryngology & Otology , Volume 124 , Issue 2 , February 2010 , pp. 137 - 140
Copyright
Copyright © JLO (1984) Limited 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1McCabe, BF. Autoimmune sensorineural hearing loss. Ann Otol Rhinol Laryngol 1979;88:585–9CrossRefGoogle ScholarPubMed
2Halligan, CS, Bauch, CD, Brey, RH, Achenbach, SJ, Bamlet, WR, McDonald, TJ et al. Hearing loss in rheumatoid arthritis. Laryngoscope 2006;116:2044–9CrossRefGoogle ScholarPubMed
3Dagli, M, Sivas Acar, F, Karabulut, H, Eryilmaz, A, Erkol Inal, E. Evaluation of hearing and cochlear function by DPOAE and audiometric tests in patients with ankylosing spondilitis. Rheumatol Int 2007;27:511–16CrossRefGoogle ScholarPubMed
4Eryilmaz, A, Dagli, M, Karabulut, H, Sivas Acar, F, Erkol Inal, E, Gocer, C. Evaluation of hearing loss in patients with ankylosing spondylitis. J Laryngol Otol 2007;121:845–9CrossRefGoogle ScholarPubMed
5Bayazit, YA, Yilmaz, M, Gunduz, B, Altinyay, S, Kemaloglu, YK, Onder, M et al. Distortion product otoacoustic emission findings in Behçet's disease and rheumatoid arthritis. ORL J Otorhinolaryngol Relat Spec 2007;69:233–8CrossRefGoogle ScholarPubMed
6Dagli, M, Eryilmaz, A, Tanrikulu, S, Aydin, A, Gonul, M, Gul, U et al. Evaluation of cochlear involvement by distortion product otoacoustic emission in Behçet's disease. Auris Nasus Larynx 2008;35:333–7CrossRefGoogle ScholarPubMed
7Hatzopoulos, S, Amoroso, C, Aimoni, C, Lo Monaco, A, Govoni, M, Martini, A. Hearing loss evaluation of Sjögren's syndrome using distortion product otoacoustic emissions. Acta Otolaryngol Suppl 2002;548:20–5CrossRefGoogle Scholar
8Karatas, E, Onat, AM, Durucu, C, Baglam, T, Kanlikama, M, Altunoren, O et al. Audiovestibular disturbance in patients with systemic lupus erythematosus. Otolaryngol Head Neck Surg 2007;136:82–6CrossRefGoogle ScholarPubMed
9Kastanioudakis, I, Ziavra, N, Voulgari, PV, Exarchakos, G, Skevas, A, Drosos, AA. Ear involvement in systemic lupus erythematosus patients: a comparative study. J Laryngol Otol 2002;116:103–7CrossRefGoogle ScholarPubMed
10Sestak, AL, Nath, SK, Harley, JB. Systemic lupus erythematosus: genetics of systemic lupus erythematosus: how far have we come? Rheum Dis Clin North Am 2005;31:223–44CrossRefGoogle ScholarPubMed
11Fukushima, N, Fukushima, H, Cureoglu, S, Schachern, PA, Paparella, MM. Hearing loss associated with systemic lupus erythematosus: temporal bone histopathology. Otol Neurotol 2006;27:127–8CrossRefGoogle ScholarPubMed
12Sone, M, Schachern, PA, Paparella, MM, Morizono, N. Study of systemic lupus erythematosus in temporal bones. Ann Otol Rhinol Laryngol 1999;108:338–44CrossRefGoogle ScholarPubMed
13Gussen, R. Polyarteritis nodosa and deafness. A human temporal bone study. Arch Otorhinolaryngol 1977;217:263–71CrossRefGoogle ScholarPubMed
14Jenkins, HA, Pollak, AM, Fisch, U. Polyarteritis nodosa as a cause of sudden deafness. A human temporal bone study. Am J Otolaryngol 1981;2:99–107CrossRefGoogle ScholarPubMed
15Yoon, TH, Paparella, MM, Schachern, PA. Systemic vasculitis: a temporal bone histopathologic study. Laryngoscope 1989;99:600–9CrossRefGoogle ScholarPubMed
16Gladman, DD, Urowitz, MB, Kagal, A, Hallett, D. Accurately describing changes in disease activity in systemic lupus erythematosus. J Rheumatol 2000;27:377–9Google ScholarPubMed
17Anonymous. Guidelines for screening for hearing impairment and middle ear disorders. ASHA 1989;1:7–71Google Scholar
18Anonymous. Guidelines for screening for hearing impairment and middle ear disorders. Working Group on Acoustic Immittance Measurements and the Committee on Audiologic Evaluation. ASHA 1990;(suppl 2):17–24Google Scholar
19Stephens, SDG, Luxon, L, Hinchcliffe, R. Immunological disorders and auditory lesions. Audiology 1982;21:128–48CrossRefGoogle ScholarPubMed
20Andonopoulos, AP, Naxakis, S, Goumas, P, Lygatsikas, C. Sensorineural hearing disorders in systemic lupus erythematosus. A controlled study. Clin Exp Rheumatol 1995;13:137–41Google ScholarPubMed
21Gomides, AP, do Rosário, EJ, Borges, HM, Gomides, HH, de Pádua, PM, Sampaio-Barros, PD. Sensorineural dysacusis in patients with systemic lupus erythematosus. Lupus 2007;16:987–90CrossRefGoogle ScholarPubMed
22Roverano, S, Cassano, G, Paira, S, Chiavarini, J, Graf, C, Rico, L et al. Asymptomatic sensorineural hearing loss in patients with systemic lupus erythematosus. J Clin Rheumatol 2006;12:217–20CrossRefGoogle ScholarPubMed
23Keithley, EM, Chen, MC, Linthicum, F. Clinical diagnoses associated with histologic findings of fibrotic tissue and new bone in the inner ear. Laryngoscope 1998;108:87–91CrossRefGoogle ScholarPubMed
24Petri, M. Clinical features of systemic lupus erythematosus. Curr Opin Rheumatol 1995;7:395–401CrossRefGoogle ScholarPubMed